MedTrace Logo

PRactice of VENTilation in Patients With ARDS Due to COVID-19 vs Pneumonia

NCT05650957 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7145

Last updated 2024-07-03

No results posted yet for this study

Summary

This study aims to compare epidemiology, management of invasive ventilation and outcomes in critically ill patients with COVID-19 ARDS and ARDS from another pulmonary infection. The investigators will use individual patient data from four recently published large observational COVID-9 studies, including the 'Practice of VENTilation in COVID-19 patients' (PRoVENT-COVID) study, the 'Epidemiology of COVID-19 patients in the ICU' (EPICCoV) study, the 'SATI-COVID-19 - Clinical Characteristics and Outcomes of Patients With COVID-19 on Mechanical Ventilation in Argentina: a Prospective, Multicenter Cohort Study' and the CIBERESUCICOVID - Personalized Risk and Prognosis Factors and Follow-up at One Year of the Patients Hospitalized in the Spanish Intensive Care Units Infected with COVID -19' study. The investigators will use the individual patient data from ARDS patients with another pulmonary infection from the 'LUNG -SAFE - Large Observational Study to UNderstand the Global Impact of Severe Acute Respiratory FailurE' study and the 'ERICC - Epidemiology of Respiratory Insufficiency in Critical Care' study.

Conditions

  • Acute Respiratory Distress Syndrome
  • COVID-19
  • Pneumonia
  • Mechanical Ventilation Complication

Sponsors & Collaborators

  • Carlos III Health Institute

    collaborator OTHER_GOV

  • University of Sao Paulo

    collaborator OTHER

  • National University of Ireland, Galway, Ireland

    collaborator OTHER

  • Amsterdam UMC

    collaborator OTHER

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Principal Investigators

  • David MP van Meenen, PhD · Amsterdam UMC, location AMC

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2024-02-01
Completion
2024-02-01

Countries

  • Argentina
  • Brazil
  • Ireland
  • Netherlands
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05650957 on ClinicalTrials.gov